ALS Research Group

Umeå University Hospital

The ALS research group at Umeå University Hospital performs clinical studies, including phase 1—3 trials as well as molecular pathology research using genetic (DNA), proteomic (proteins) and metabolomic approaches.

Umeå University Hospital

In 1992, the ALS Clinical Center was established at Umeå University Hospital. This is now the principal center for diagnosing and caring of patients with neuromuscular diseases in northern Sweden. The clinical team also performs second-opinion evaluations of patients from other parts of Sweden and from abroad. Since 1992 the center has conducted clinical phase 1—3 trials which concern investigator initiated clinical trials as well as studies with the industry. The ALS Clinical Center is part of the larger ALS Research Consortium in Umeå that also performs genetic, histopathology and molecular-pathology studies. The focus is on studying SOD1 and its role as a prion in causing cell death.

Umeå University, Postadress:, Umeå, Sweden

Our Specialists

Peter Andersen

Professor of Neurology and Senior Neurologist

Professor Andersen obtained his medical degree from Copenhagen University and specialised in […]

Peter Andersen
Current trials
Phase iii


Industry trial

Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound ‘AMX0035’ for the treatment of ALS.

Read more